Rezafungin Peritoneal Diffusion for Intra-abdominal Candidiasis

Not yet recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

May 1, 2026

Study Completion Date

September 1, 2026

Conditions

Intra-Abdominal InfectionCandidaAbdominal Surgery PatientsCritically Ill Intensive Care Unit Patients

Trial Locations (1)

CHRU de Nancy, Vandœuvre-lès-Nancy

All Listed Sponsors

collaborator

Mundipharma Research GmbH & Co KG

INDUSTRY

lead

Central Hospital, Nancy, France

OTHER

NCT07093203 - Rezafungin Peritoneal Diffusion for Intra-abdominal Candidiasis | Biotech Hunter | Biotech Hunter